TRIM56 Suppresses Multiple Myeloma Progression by Activating TLR3/TRIF Signaling

Ying Chen(First Affiliated Hospital of Xi'an Jiaotong University), Mei Zhang(First Affiliated Hospital of Xi'an Jiaotong University)
Yonsei Medical Journal
December 6, 2017
10.3349/ymj.2018.59.1.43
Cited by 29

Related Papers

miR-181a increases FoxO1 acetylation and promotes granulosa cell apoptosis via SIRT1 downregulation
|Cell Death and Disease|2017|174
Dihydroartemisinin Induces Growth Arrest and Overcomes Dexamethasone Resistance in Multiple Myeloma
|Frontiers in Oncology|2020|18
Dendritic cell-activated cytokine-induced killer cell-mediated immunotherapy is safe and effective for cancer patients >65 years old
|Oncology Letters|2016|9